Gallbladder cancer other imaging findings
Jump to navigation
Jump to search
|
Gallbladder cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gallbladder cancer other imaging findings On the Web |
|
American Roentgen Ray Society Images of Gallbladder cancer other imaging findings |
|
Risk calculators and risk factors for Gallbladder cancer other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
FDG-PET scan may be helpful in the diagnosis of the gallbladder.
Other Imaging Findings
- Given the rate of high incidence of metastases in gallbladder cancer, FDG(fluorodeoxyglucose), PET(positron emission tomography) scan is particularly useful in identifying metastases.[1][2][3][4][5]
- PET scan is useful in diagnosing abnormal lesions and detecting residual disease after cholecystectomy.
- PET scan has the ability to detect occult metastasis in patients with potentially resectable tumors and changes the management in almost 25% of the patients.
- Percutaneous transhepatic cholecystoscopy and Percutaneous transhepatic fine needle aspiration are helpful in the evaluation of gallbladder polyps.
References
- ↑ Corvera, Carlos U.; Blumgart, Leslie H.; Akhurst, Timothy; DeMatteo, Ronald P.; D’Angelica, Michael; Fong, Yuman; Jarnagin, William Robert (2008). "18F-fluorodeoxyglucose Positron Emission Tomography Influences Management Decisions in Patients with Biliary Cancer". Journal of the American College of Surgeons. 206 (1): 57–65. doi:10.1016/j.jamcollsurg.2007.07.002. ISSN 1072-7515.
- ↑ Oe A, Kawabe J, Torii K, Kawamura E, Higashiyama S, Kotani J, Hayashi T, Kurooka H, Tsumoto C, Kubo S, Shiomi S (2006). "Distinguishing benign from malignant gallbladder wall thickening using FDG-PET". Ann Nucl Med. 20 (10): 699–703. PMID 17385310.
- ↑ Anderson CD, Rice MH, Pinson CW, Chapman WC, Chari RS, Delbeke D (2004). "Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma". J. Gastrointest. Surg. 8 (1): 90–7. PMID 14746840.
- ↑ Butte JM, Redondo F, Waugh E, Meneses M, Pruzzo R, Parada H, Amaral H, De La Fuente HA (2009). "The role of PET-CT in patients with incidental gallbladder cancer". HPB (Oxford). 11 (7): 585–91. doi:10.1111/j.1477-2574.2009.00104.x. PMC 2785954. PMID 20495711.
- ↑ Corvera CU, Blumgart LH, Akhurst T, DeMatteo RP, D'Angelica M, Fong Y, Jarnagin WR (2008). "18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer". J. Am. Coll. Surg. 206 (1): 57–65. doi:10.1016/j.jamcollsurg.2007.07.002. PMID 18155569.